*Department of Psychology, Oklahoma State University, Stillwater, Oklahoma; †Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; ‡Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; §Center for the Promotion of Treatment Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and ‖Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Inflamm Bowel Dis. 2013 Nov;19(12):2666-72. doi: 10.1097/MIB.0b013e3182a82b15.
Adjusting to symptom flares, treatment regimens, and side effects places youth with inflammatory bowel disease (IBD) at increased risk for emotional and behavioral problems and adverse disease outcomes. Implementation of psychosocial screening into clinical practice remains a challenge. This study examines the clinical utility of health-related quality of life (HRQOL) screening in predicting disease outcome and healthcare utilization.
One hundred twelve youth of 7 to 18 years diagnosed with IBD and their parents. Youth completed standardized measures of HRQOL and depression. Parents completed a proxy report of HRQOL. Pediatric gastroenterologists provided the Physician Global Assessment. Families were recruited from a pediatric gastroenterology clinic. Retrospective chart reviews examined disease outcome and healthcare utilization for 12 months after baseline measurement.
Linear regressions, controlling for demographic and disease parameters, revealed that baseline measurement of youth and parent proxy-reported HRQOL predicted the number of IBD-related hospital admissions, gastroenterology clinic visits, emergency department visits, psychology clinic visits, telephone contacts, and pain management referrals over the next 12 months. Disease outcome was not significant.
Lower HRQOL was predictive of increased healthcare utilization among youth with IBD. Regular HRQOL screening may be the impetus to providing better case management and allocating resources based on ongoing care needs and costs. Proactive interventions focused on patients with poor HRQOL may be an efficient approach to saving on healthcare costs and resource utilization.
炎症性肠病(IBD)患儿需要适应症状发作、治疗方案和副作用,这使他们面临更高的情绪和行为问题以及不良疾病结局风险。将心理社会筛查纳入临床实践仍然具有挑战性。本研究旨在探讨健康相关生活质量(HRQOL)筛查在预测疾病结局和医疗保健利用方面的临床实用性。
共纳入 112 名 7 至 18 岁确诊为 IBD 的患儿及其父母。患儿完成了 HRQOL 和抑郁的标准化评估,父母则完成了 HRQOL 的代理报告。儿科胃肠病学家提供了医生整体评估。研究从儿科胃肠病诊所招募了参与者。回顾性病历审查考察了基线测量后 12 个月内疾病结局和医疗保健利用情况。
在控制人口统计学和疾病参数后,线性回归显示,患儿和家长代理报告的 HRQOL 基线测量可预测 IBD 相关住院、胃肠病诊所就诊、急诊就诊、心理诊所就诊、电话联系和疼痛管理转介的次数在接下来的 12 个月内。疾病结局没有统计学意义。
HRQOL 较低与 IBD 患儿医疗保健利用率增加有关。定期进行 HRQOL 筛查可能有助于根据持续的护理需求和成本提供更好的病例管理和资源分配。针对 HRQOL 较差患者的主动干预可能是节省医疗保健成本和资源利用的有效方法。